Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDown with the Erythropoietin. Long Live the Erythropoietin
Current Drug Targets, 10/23/09
Buemi M et al. – The understanding of the regeneration mechanisms of complex structures in the adult salamander has opened original lines of research. Regenerative Medicine tries to develop therapeutic pathways through the stimulation of natural regenerative processes in humans.
Related Articles
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 87%
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Haematologica, 10/21/09
Relevance Score: 85%
School of Pharmacy Hopes to Close Clinical Gap for Elderly Blood Disorder
Internet Source, 11/05/09
Relevance Score: 84%
Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants
Journal of Pharmacology and Experimental Therapeutics, 10/09/09
Relevance Score: 84%
A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia
New England Journal of Medicine, 11/05/09
Relevance Score: 83%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
No evidence for functional selectivity of proxyfan at the human histamine H3-receptor coupled to defined Gi/Go protein heterotrimers
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Metabolic Fate of Lactoferricin Based Antimicrobial Peptides: Effect of Truncation and Incorporation of Amino Acid Analogs on the in vitro Metabolic Stability
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Sponsor
Article Search
Sponsor